

HY-169937 · 50 mg
MedChemExpress · Cat: HY-169937
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/r-sr-c-107.htmlDescription
R -SR-C-107 is an orally available inhibitor of ENL YEAST domain-containing protein designed to target acute myeloid leukemia AML . R -SR-C-107 targets ENL with IC50 and KD of 40 nM and 144 nM, respectively. R -SR-C-107 demonstrates in vivo efficacy in a xenograft mouse model of AML, with a tumor regression rate of 45 % at a dose of 200 mg/kg PO; QD .

